Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Bought rights offer and waiting for 2 more days

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Jun 04, 2021 8:31am

66 Views

Post# 33328354

RE:RE:Bought rights offer and waiting for 2 more days

They're having AGM today so they don't have to address another CRL or delay in front of cameras or a mic

realstocky wrote:

if we get no nr tomorrow evening...we should be good... 10+$ In fact, im pretty sur we're good since lmnl + kedrion made a 100M$ deal for it, lmnl knows from their contacts at FDA, correspondance etc... if they expected a fail, that deal wouldnt have happen.

StockReddy wrote: What's the point investing in stocks? if we loose even after FDA approval? I am strongly believing that this will move to above $12 (~15.21CAD) if FDA accepts ryplazim.